The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
Clinical trial NCT03739203 · COMPLETED
Trial details
- NCT number
- NCT03739203
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-10
- Primary completion
- 2021-09-06
- Enrollment
- 752
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.